HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China

HER2 and BRAF mutation in colorectal cancer patients: a retrospective study in Eastern China

Objective To investigate the frequency and prognostic role of the human epidermal growth factor receptor 2 gene (HER2) and BRAF V600E gene mutation in Chinese patients with colorectal cancer (CRC). Methods Clinicopathological and survival information from 480 patients with stage I–III CRC were revie...

Full description

Bibliographic Details
Main Authors:	Xiangyan Zhang, Jie Wu, Lili Wang, Han Zhao, Hong Li, Yuhe Duan, Yujun Li, Ping Xu, Wenwen Ran, Xiaoming Xing
Format:	Article
Language:	English
Published:	PeerJ Inc. 2020-02-01
Series:	PeerJ
Subjects:	Human epidermal growth factor receptor 2 gene BRAF mutation Colorectal cancer Prognosis
Online Access:	https://peerj.com/articles/8602.pdf

Similar Items

Prognostic value of the combination of microsatellite instability and BRAF mutation in colorectal cancer
by: Yang Y, et al.
Published: (2018-09-01)

The prevalence of KRAS and BRAF mutation in colorectal cancer patients in Bali
by: Ayu Dewi Ni Nyoman, et al.
Published: (2022-03-01)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
by: Daeyoun David Won, et al.
Published: (2017-06-01)

BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
by: Laure Moisset, et al.
Published: (2019-06-01)

Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives
by: Alessandro Ottaiano, et al.
Published: (2022-03-01)

<i>BRAF</i> Inhibitors in <i>BRAF-Mutated</i> Colorectal Cancer: A Systematic Review
by: Wajeeha Aiman, et al.
Published: (2023-12-01)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
by: İvo Gökmen, et al.
Published: (2023-09-01)

BRAF mutation is associated with poor clinicopathological outcomes in colorectal cancer: A meta-analysis
by: Yujie Li, et al.
Published: (2017-01-01)

<i>BRAF</i> Mutations in Colorectal Liver Metastases: Prognostic Implications and Potential Therapeutic Strategies
by: Pei-Pei Wang, et al.
Published: (2022-08-01)

Perspectives in the Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer Patients
by: Gerardo Rosati, et al.
Published: (2021-03-01)

Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China
by: Xiangyan Zhang, et al.
Published: (2018-02-01)

PROMISES FOR TREATING COLON CANCER PATIENTS WITH BRAF GENE MUTATION
by: M. Yu. Fedyanin, et al.
Published: (2015-02-01)

BRAF mutation in colorectal cancer: An update
by: Colombo Alfredo, et al.
Published: (2023-01-01)

Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
by: Wen-Long Guan, et al.
Published: (2020-11-01)

KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis
by: Abolfazl Yari, et al.
Published: (2020-06-01)

Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
by: Qiwei Yang, et al.
Published: (2018-10-01)

High <i>Wnt2</i> Expression Confers Poor Prognosis in Colorectal Cancer, and Represents a Novel Therapeutic Target in BRAF-Mutated Colorectal Cancer
by: Huan Liu, et al.
Published: (2023-06-01)

BRAF Non-V600 Mutations in Metastatic Colorectal Cancer
by: Junjia Liu, et al.
Published: (2023-09-01)

BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in <i>BRAF</i>-Mutated Metastatic Colorectal Cancer—A Case Series Study <i>Target Therapy of</i> BRAF-<i>Mutated mCRC</i>
by: Jen-Hao Yeh, et al.
Published: (2021-12-01)

BRAF mutation and its inhibitors in sarcoma treatment
by: Haotian Liu, et al.
Published: (2020-07-01)

Comprehensive Landscape of BRAF Variant Classes, Clonalities, and Co-Mutations in Metastatic Colorectal Cancer Using ctDNA Profiling
by: Benny Johnson, et al.
Published: (2024-02-01)

Braf protein mutation and its significancy within patients with melanoma
by: Julia Kuchnicka, et al.
Published: (2022-08-01)

The Frequency and Clinical Implications of the BRAF Mutation in Papillary Thyroid Cancer Patients in Korea Over the Past Two Decades
by: A Ram Hong, et al.
Published: (2014-12-01)

Determination of the Prevalence of Microsatellite Instability, <i>BRAF</i> and <i>KRAS</i>/<i>NRAS</i> Mutation Status in Patients with Colorectal Cancer in Slovakia
by: Tomas Rendek, et al.
Published: (2024-03-01)

The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses
by: Yungchang Chen, et al.
Published: (2023-01-01)

The Role of BRAF in Metastatic Colorectal Carcinoma–Past, Present, and Future
by: Angela Djanani, et al.
Published: (2020-11-01)

BRAF Mutated Colorectal Cancer: New Treatment Approaches
by: Javier Molina-Cerrillo, et al.
Published: (2020-06-01)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
by: Aleksandra Bożyk, et al.
Published: (2021-03-01)

A BRAF mutation-associated gene risk model for predicting the prognosis of melanoma
by: Xiang Huang, et al.
Published: (2023-05-01)

V-raf murine sarcoma viral oncogene homolog B (BRAF) mutations in hairy cell leukaemia
by: Neeraj Arora, et al.
Published: (2015-01-01)

The possibilities of therapy of patients with metastatic colorectal cancer with <i>BRAF</i> V600E mutation. Clinical cases
by: Elizaveta M. Polyanskaya, et al.
Published: (2023-05-01)

Targeting BRAF and RAS in Colorectal Cancer
by: Helene Bellio, et al.
Published: (2021-05-01)

Analysis of KRAS, NRAS, and BRAF Mutations, Microsatellite Instability, and Relevant Prognosis Effects in Patients With Early Colorectal Cancer: A Cohort Study in East Asia
by: Yang Li, et al.
Published: (2022-06-01)

Somatic mutations in colorectal cancer: regional experience
by: Nikolai A. Ognerubov, et al.
Published: (2022-07-01)

Incidence of BRAF mutations in cutaneous melanoma: histopathological and molecular analysis of a Ukrainian population
by: Oleksandr Dudin, et al.
Published: (2023-03-01)

Low frequency of BRAF and KRAS mutations in Chinese patients with low-grade serous carcinoma of the ovary
by: Yan Xu, et al.
Published: (2017-12-01)

Immune Profile of BRAF-Mutated Metastatic Colorectal Tumors with Good Prognosis after Palliative Chemotherapy
by: Jeong Eun Kim, et al.
Published: (2022-05-01)

Clinicopathological Features of Non-Small Cell Lung Carcinoma with BRAF Mutation
by: Andrea Ambrosini-Spaltro, et al.
Published: (2023-11-01)

Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
by: O. I. Kit, et al.
Published: (2016-06-01)

Real‐world treatment and outcomes of patients with metastatic BRAF mutant colorectal cancer
by: Ting Xu, et al.
Published: (2023-05-01)